Open AccessAt a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease
Author(s) -
Thomas Cascino,
Ankit A. Desai,
Yogendra Kanthi
Publication year - 2021
Publication title -
current opinion in pulmonary medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.937
H-Index - 75
eISSN - 1531-6971
pISSN - 1070-5287
DOI - 10.1097/mcp.0000000000000792
Subject(s) - medicine , pulmonary hypertension , disease , intensive care medicine , covid-19 , pandemic , hypoxia (environmental) , coronavirus , lung , cardiology , infectious disease (medical specialty) , chemistry , organic chemistry , oxygen
The coronavirus disease 2019 (COVID-19) pandemic has led to almost 3,000,000 deaths across 139 million people infected worldwide. Involvement of the pulmonary vasculature is considered a major driving force for morbidity and mortality. We set out to summarize current knowledge on the acute manifestations of pulmonary vascular disease (PVD) resulting from COVID-19 and prioritize long-term complications that may result in pulmonary hypertension (PH).